Brief: Astrazeneca Pharma India March-Quarter PAT 582.5 Million Rupees
30/05/2025 14:47
May 30 (Reuters) - Astrazeneca Pharma India Ltd ASTR.NS: ASTRAZENECA PHARMA INDIA MARCH-QUARTER PAT 582.5 MILLION RUPEES ASTRAZENECA PHARMA INDIA MARCH-QUARTER REVENUE FROM OPERATIONS 4.8 BILLION RUPEES ((Reuters.Briefs@thomsonreuters.com;))
Recent news on Astrazeneca Pharma India
See all newsBrief: Astrazeneca Pharma India Receives Permission To Import And Sell Trastuzumab Deruxtecan For Additional Indication
Brief: Astrazeneca Pharma Says Bhavana Agrawal Resigns As CFO
Brief: Astrazeneca Pharma India Receives Permission To Import And Sell Benralizumab For Additional Indication
Brief: Astrazeneca Pharma India Receives Permission To Import Benralizumab (Fasenra) For Additional Indication
Brief: Astrazeneca Pharma Gets Permission To Import For Sale Of Trastuzumab Deruxtecan